Phage therapy has (re) emerged as a serious possibility for combating multidrug-resistant
bacterial infections, including those caused by vancomycin-resistant Enterococcus faecium …

Enterococcus faecium is a significant multidrug-resistant pathogen. Bacteriophage cocktails
are being proposed to complement antibiotic therapy. After a screen of 8 E. faecium strains …

The deteriorating effectiveness of antibiotics is propelling researchers worldwide towards
alternative techniques such as phage therapy: curing infectious diseases using viruses of …

Vancomycin-resistant Enterococcus faecalis (VRE) has become a significant threat in
nosocomial settings. Bacteriophage (phage) therapy is frequently proposed as a potential …

Concerns regarding increased prevalence of daptomycin (DAP)-resistant strains necessitate
novel therapies for Enterococcus faecium infections. Obligately lytic bacteriophages are …

Enterococcus faecium, a commensal of the human intestine, has emerged as a hospital-
adapted, multidrug-resistant (MDR) pathogen. Bacteriophages (phages), natural predators …

Antibiotic resistant Enterococcus infections are a major health crisis that requires the
development of alternative therapies. Phage therapy could be an alternative to antibiotics …

Bacteriophages are an increasingly attractive option for the treatment of antibiotic resistant
infections, but their efficacy is difficult to discern due to confounding effects of antibiotics …

Enterococcus faecium is a member of the human gastrointestinal (GI) microbiota but can
also cause invasive infections, especially in immunocompromised hosts. Enterococci …

Colonization of the gastrointestinal tract with vancomycin-resistant Enterococcus faecium
(VRE) has become endemic in many hospitals and nursing homes in the United States …